Azithromycin + Hydroxychloroquine for neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Apr 2020: Trial started, NCT04341207
  2. 10 Apr 2020: Trial registered, NCT04341207

The trials

NCT04341207: Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients

State
State not given
Phase
Phase 2
People
1,000 planned
Started
3 Apr 2020
Primary completion
Apr 2022
Arms
Cohort 1
Results
None posted
  1. 3 Apr 2020: Trial started
  2. 10 Apr 2020: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.